On September 25, 2025, Moleculin Biotech, Inc. announced that the Canadian Intellectual Property Office plans to grant a patent for their application on "Preparation of Preliposomal Annamycin Lyophilizate." This is seen as a positive development for the company as they expect the patent to be issued soon.